Sort
4,870 grants matching “glp 1”
Closing the Cardio-Renal Preventive Treatment Gap Among Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: An Implementation Science Approach
$147,539Julio Alejandro Lamprea Montealegre · University Of California, San Francisco · K99 · FY2022 · HL
Physiological mechanisms underlying alterations in diet preference
$147,500Yada Treesukosol · California State University Long Beach · SC2 · FY2023 · GM
Physiological mechanisms underlying alterations in diet preference
$147,393Yada Treesukosol · California State University Long Beach · SC2 · FY2022 · GM
Physiological mechanisms underlying alterations in diet preference
$147,260Yada Treesukosol · California State University Long Beach · SC2 · FY2021 · GM
Evaluation of a Novel Connexin-Based Peptide for the Treatment of Diabetic Wounds
$147,249Gautam Sudhir Ghatnekar · Xequel Bio, Inc. · SB1 · FY2018 · DK
Evaluation of the entero-insular (incretin) axis in cystic fibrosis-competitive renewal.
$147,020Andrea Bridget Kelly · Children'S Hosp Of Philadelphia · R56 · FY2019 · DK
Transplantation of Multipotent Progenitor Cells in Stroke
$146,585Cesario V Borlongan · University Of South Florida · U01 · FY2009 · NS
Preclinical dosing optimization: Dosing schedule, tissue
$146,474Kanneboyina Nagaraju · Children'S Research Institute · U54 · FY2015 · HD
Cellular/molecular Interaction Between Human Adipose Derived Mesenchymal Stem Cells and Limbal Epithelial Stem Cells in Limbal Stem Cell Deficiency
$146,247Ladan Espandar · University Of Pittsburgh At Pittsburgh · K08 · FY2017 · EY
Cellular/molecular Interaction Between Human Adipose Derived Mesenchymal Stem Cells and Limbal Epithelial Stem Cells in Limbal Stem Cell Deficiency
$146,236Ladan Espandar · University Of Pittsburgh At Pittsburgh · K08 · FY2016 · EY
A New Approach to Compute PM2.5 for Health Impact Analysis
$145,856Fazlay S Faruque · University Of Mississippi Med Ctr · R21 · FY2012 · ES
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man
$145,779Patricia Sue Grigson · Pennsylvania State Univ Hershey Med Ctr · UG3 · FY2021 · DA
Non-invasive beta-cell imaging using a Ga-68-labeled glucagone-like peptide-1 ana
$145,650Gotthardt Martin · Radboud University Nijmegen Med Ctr · R01 · FY2007 · AG
Development and Applications of Bioorthogonal Chemistry: Administrative Supplement for Equipment
$145,555Qing Lin · State University Of New York At Buffalo · R35 · FY2020 · GM
Preclinical &Phase I/II Trials Of AAV-AAT Vectors
$145,500University Of Florida · R01 · FY2005 · HL
Scientific Core
$145,336Tim Mosmann · University Of Rochester · U19 · FY2011 · AI
Risperidone Pharmacokinetics in Children with Pervasive*
$145,120Children'S Hospital Med Ctr (Cincinnati) · R21 · FY2003 · HD
Secretagogue Induced Mechanisms Regulating Islet Electrical Activity
$145,001David Aaron Jacobson · Vanderbilt University · K01 · FY2011 · DK
Secretagogue Induced Mechanisms Regulating Islet Electrical Activity
$145,001David Aaron Jacobson · Vanderbilt University · K01 · FY2012 · DK
Treatment of Type 2 Diabetes with Oral Administration of Nanoencapsulated GLP-1
$144,961Thomas F Conway · Therapyx, Inc. · R43 · FY2006 · DK
Preclinical dosing optimization: Dosing schedule, tissue
$144,695Kanneboyina Nagaraju · Children'S Research Institute · U54 · FY2012 · HD
EFFECT OF EXENTIDE ON INSULIN SECRETION AND BETA CELL MASS
$144,393Franco Battista Ennio Folli · Texas Biomedical Research Institute · P51 · FY2011 · RR
Development of CB-CAPs as Lupus Biomarkers
$143,725Daniel F Graziano · Stagemark, Inc. · R43 · FY2006 · AR
Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer
$142,814Gregory John Johnson · Jsk Therapeutics, Inc. · R44 · FY2014 · CA
CORE--GENE AND CELLULAR THERAPY
$142,758University Of California Los Angeles · P30 · FY2000 · AI